FAWAD IQBAL JANJUA, JAMSHID SIDDIQUE, SADIA KHAN
Liver cirrhosis (LC), is the end-stage of chronic Liver disease, is the major risk factor contributing in the development of the Hepatocellular Carcinoma (HCC). It is the leading cause of deaths worldwide being the 14th most common death cause globally. According to previous studies, 1%-57% mortalities with 1-year has been reported on the sub classification of LC mortality. The Emerging trends in the management of LC patients is prevention, intervention, avoiding the clinical decompensating and liver transplantation. In this review we summarized the impact of LC on the management and prognosis of patients with primary Liver carcinoma or non-hepatic malignancies.